Diabetes mellitus in the Russian Federation: Arguments and facts
Authors:
Open Access
- 15 October 2016
- journal article
- Published by Consilium Medicum in Terapevticheskii arkhiv
- Vol. 88 (10) , 4-8
Abstract
Diabetes mellitus (DM) is a fast-spreading non-communicable disease epidemic of the 21st century. According to the Russian State Register, in 2015 a total of 4.3 million patients were registered for seeking medical advice for DM. were registered in 2015. However, the first NATION epidemiological survey aimed to actively screen type 2 DM (T2DM) in the population of Russia has shown that the true prevalence of T2DM is twice as high as the registered one, accounting for 5.4%. The proportion of previously undiagnosed T2DM was 54%. The highest prevalence of T2DM was seen in individuals older than 45 years and in those with obesity or cardiovascular diseases. The prevalence of prediabetes was 19.3%. The main cause of death in DM patients is cardiovascular diseases. Nonmedical and indirect costs are more than a quarter of the economic burden. The medical costs of treatment for patients with DM and complications are thrice higher than those in uncomplicated DM subjects.Keywords
This publication has 8 references indexed in Scilit:
- Prevalence of type 2 diabetes mellitus (T2DM) in the adult Russian population (NATION study)Diabetes Research and Clinical Practice, 2016
- The prevalence of type 2 diabetes mellitus in the adult population of Russia (NATION study)Diabetes mellitus, 2016
- Diabetes mellitus as an economic problem in Russian FederationDiabetes mellitus, 2016
- Russian multicentre type 2 diabetes screening program in patients with cardiovascular diseaseDiabetes mellitus, 2016
- National register of diabetes mellitus in Russian Federation.Diabetes mellitus, 2015
- Federal targeted programme 'Prevention and Management of Socially Significant Diseases (2007-2012)': results of the 'Diabetes mellitus' sub-programmeDiabetes mellitus, 2013
- Mortality in type 2 diabetes mellitus: magnitude of the evidence from a systematic review and meta-analysisBritish Journal of Diabetes, 2013
- Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitusDiabetes Research and Clinical Practice, 2011